Answers are grounded in this paper and cite their sources.
HOXB5 was a potential prognostic biomarker in HCC patients and targeting this loop may provide a promising treatment strategy for the inhibition of HOXB5-mediated HCC metastasis.
No takes yet. Share an insight, caveat, or question.
He et al. (2021) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: